| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7097854 Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006088716A1 Substituted tetralins as selective estrogen receptor-beta agonists |
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |
| 08/24/2006 | WO2006086986A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | WO2006086985A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | WO2006086984A1 Process for making trans-1-((1r, 3s)-6-chloro-3-phenylindan-1-yl)-3, 3-dimethylpiperazine |
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189689 Arginine mimetics as factor Xa inhibitors |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | DE102005005875A1 3-Amino-2-aminmethyl-phenol-Derivate und diese Verbindungen enthaltende Färbemittel 3-amino-2-amine, methyl-phenol derivatives and coloring agents containing these compounds |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2597622A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597620A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597615A1 Process for making trans-1-((1r, 3s)-6-chloro-3-phenylindan-1-yl)-3, 3-dimethylpiperazine |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 08/23/2006 | EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 08/23/2006 | EP1692101A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 08/23/2006 | EP1692098A1 Alpha-ketoamide derivative, and production method and use thereof |
| 08/23/2006 | EP1692093A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 08/23/2006 | EP1691800A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 08/23/2006 | EP1581480B1 Cyclopentyl-substituted glutaramide compounds as endopeptidase-v inhibitors |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/23/2006 | CN1271209C Microbial biotransformation |
| 08/23/2006 | CN1271167C Organic electroluminescent element |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271030C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1-yl)-phenoxy-ethyl-pyrrolidine |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/17/2006 | WO2006086374A2 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2006084833A1 Monohydrochloride salt of 1- [3- [3- (4-chlorophenyl) propoxy] propyl] -piperidine |
| 08/17/2006 | WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183903 Reacting 4-(alpha-(p-chlorophenyl)benzyl)-1-leaving group-alkylpiperazine with protected 1-hydroxy-1-(4-(p-hydroxyphenyl)-3-butynyl)urea to form 1-(4-(p-(4-(alpha-(p-chlorophenyl)benzyl)-1-piperazin-1-ylalkyl)phenyl)-3-butynyl)-1-hydroxyurea; preparation of intermediates |
| 08/17/2006 | US20060183791 Substituted p-diaminobenzene derivatives |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 08/17/2006 | CA2597016A1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 08/16/2006 | EP1690858A1 Monohydrochloride salt of 1-¬3-¬3-(4-chlorophenyl)propoxy|propyl|-piperidine |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1690824A1 Mobile work platform |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689702A1 Organic compounds |
| 08/16/2006 | EP1689698A1 Bis-cationic compounds and use thereof |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1301467B1 9-substituted minocycline compounds |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/16/2006 | CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269793C Method for producing 3,3-diarylpropylamines |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/15/2006 | US7091364 Introducing in a reactor a5-amino-3-(carboxyalkyl)-4-cyano-2-thiophenecarboxylic acid, potassium carbonate and a quaternaryammonium salt as catalyst acetone solvent and methyl bromo acetate, heating and cooling |
| 08/15/2006 | US7091354 Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| 08/15/2006 | US7091341 Adding to a reaction medium comprising isocyanates a catalytic system which comprises imidazole or one of its derivatives;allowing the reaction to progress; isolating polyisocyanurate polyisocyanates |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7090703 oxidation base hair dye; nontoxic, colorfast |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/10/2006 | WO2006083924A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083003A1 Novel benzamidine compound |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082497A1 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled compounds by thermally induced free radical carbonylation |
| 08/10/2006 | WO2006082477A1 Piperazino based photoinitiators |
| 08/10/2006 | WO2006082456A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
| 08/10/2006 | US20060178490 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 08/10/2006 | US20060178438 Muscarinic agonists |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178360 N(2-hydroxyethyl)-4-methoxy-N,2,6-trimethylbenzene- sulphonamide; analgesic, antiinflammatory agent; hyperalgesia and major algesia connected with other pathological conditions such as cancer |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | CA2596444A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | CA2594845A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
| 08/10/2006 | CA2587383A1 Piperazino based photoinitiators |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1687262A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators |